← Return to Tidvak (tisotumab vedotin) therapy for Metastatic Cervical Cancer
DiscussionTidvak (tisotumab vedotin) therapy for Metastatic Cervical Cancer
Gynecologic Cancers | Last Active: Jun 9, 2025 | Replies (26)Comment receiving replies
Replies to "@margitdill This is such good news. Thank you for coming back and sharing this with us...."
Connect

PS the side effects ebb and flow throughout the interim period - between treatments. I might feel yucky in the morning but pretty good in the early evening. Sometimes I’ve had 3 good days in a row then boom, I feel yucky again. It’s very inconsistent!